7 results about "Fructus phyllanthi" patented technology

The invention relates to the technical field of functional product preparation, and provides a rhizoma polygonati and saussurea involucrata bone marrow peptide tablet as well as a preparation method and application thereof. The rhizoma polygonati and saussurea involucrata bone marrow peptide tablet is prepared from the following components: collagen peptide powder, L-isoleucine, a compound nutrient supplement, rhizoma polygonati, sorbitol, yak bone marrow peptide powder, fructus phyllanthi, fructus alpiniae oxyphyllae, mulberry powder, a saussurea involucrata culture and magnesium stearate. All the components of the rhizoma polygonati and saussurea involucrata bone marrow peptide tablet disclosed by the invention have a synergistic effect, so that the effects of conditioning sub-health, maintaining joints and assisting in treating diseases can be achieved.

The invention provides a liver-protecting medicinal and edible traditional Chinese medicine composition, a medicinal and edible product, a preparation method and application, and particularly belongs to the technical field of medicinal and edible traditional Chinese medicines. The medicinal and edible traditional Chinese medicine composition is prepared from the following components in parts by weight: 1 to 3.5 parts of semen cassiae, 0.5 to 2.5 parts of semen hoveniae, 0.1 to 1.5 parts of fructus phyllanthi and 0.1 to 1.5 parts of spica prunellae. The traditional Chinese medicine composition has the effect of remarkably improving the fatty liver and the non-alcoholic steatohepatitis, and a strategy which is low in cost and free of toxic and side effects can be provided for preventing or treating the non-alcoholic steatohepatitis.

The invention provides Wickerhamomyces anomalus and an application thereof. The Wickerhamomyces anomalus provided by the invention is preserved in the China Center for Type Culture Collection on December 5, 2024, and the preservation number of the Wickerhamomyces anomalus is CCTCC NO: M 20242728. The Wickerhamomyces anomalus provided by the invention is suitable for brewing fruit wine, especially fructus phyllanthi fruit wine.

The invention discloses a traditional Chinese medicine composition for treating hepatic fibrosis, a traditional Chinese medicine preparation and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 90 to 110 parts of meconopsis, 40 to 60 parts of concretio silicea bambusae, 90 to 110 parts of flos carthami, 90 to 110 parts of fructus chebulae, 40 to 60 parts of radix inulae, 30 to 50 parts of herba taxilli paste, 90 to 110 parts of fructus phyllanthi and 3 to 20 parts of stigma croci. The invention further discloses a traditional Chinese medicine preparation for treating hepatic fibrosis and a preparation method thereof. The traditional Chinese medicine preparation can effectively solve the problems of low application safety and high curative effect heterogeneity of western medicines aiming at hepatic fibrosis in the non-alcoholic fatty liver disease at present.

The novel use of a medicinal and edible composition based on a qi regulating, blood circulating and toxin removing method in terms of amelioration of alcoholic fatty liver disease and chemical liver injury, uric acid reduction, etc. The medicinal and edible composition is prepared from the following raw material medicines by parts by weight: 3-13 parts of ginseng, 5-15 parts of fructus phyllanthi, 5-15 parts of raw coix seed, 1-12 parts of fructus citri, 1-12 parts of exocarpium citri grandis and 10-25 parts of dandelion.

The invention discloses a composition for inflammation conditioning sub-health and a preparation method thereof, and belongs to the technical field of health care products. The composition is prepared from the following raw materials in parts by mass: 20 to 25 parts of herba taraxaci, 7 to 10.5 parts of flos lonicerae, 18 to 23 parts of fructus phyllanthi, 2 to 5 parts of semen brassicae junceae, 12 to 18.4 parts of chickpea peptide, 6 to 10 parts of radix acanthopanacis semticosi, 3.1 to 6 parts of semen raphani and 2 to 5.2 parts of fructus perillae. The composition provided by the invention can effectively reduce the levels of key inflammatory factors such as TNF-alpha and IL-1beta, and conditions the inflammation sub-health symptoms.

The invention discloses a salivation promoting powder buccal cigarette which is composed of the following components in percentage by weight: 30%-55% of microcrystalline cellulose, 5%-15% of a salivation promoting powder formula, 1%-10% of a humectant, 1%-20% of a flavoring agent, 0.5%-6% of an acid-base regulator, 1%-30% of nicotine salt and 35%-60% of water. The sum of the weight percentages of the microcrystalline cellulose, the salivation promoting powder formula and the humectant is not higher than 60%, and the weight percentage ratio of the salivation promoting powder formula to the nicotine salt is 1: (1.5-2.5). 10% of the body fluid generating powder is added, the effect is remarkable, various plant components (such as plums, dendrobium nobile, radix ophiopogonis and fructus phyllanthi) in the body fluid generating powder have a synergistic effect, salivary secretion is stimulated, and the body fluid generating feeling fed back by a user is improved by 60% or above; plum and liquorice effectively provide salivation promoting and sweet aftertaste taste; the formula of the salivation promoting powder is cooperated with the humectant, so that the moist feeling of buccal cigarettes is prolonged, and the oral dryness is reduced.